Re: Disitamab Vedotin plus Toripalimab in HER2-expressing Advanced Urothelial Cancer

European Urology 2026

View at publisher

Authors: Ping Liu, Jinbo Chen, Jumei Zhou

DOI: 10.1016/j.eururo.2026.01.020

Cited by: 0

References: 5

Fields of Study & Subjects

Bladder and Urothelial Cancer Treatments Cancer Immunotherapy and Biomarkers Lung Cancer Treatments and Mutations

References 5